Search API
Baricitinib (OLUMIANT) in combination with remdesivir met the primary endpoint of reduction of time to recovery in comparison with remdesivir
09/14/2020 - 14:31
REGN-COV2 comprises two monoclonal antibodies and was designed specifically by Regeneron to block the infectivity of SARS-CoV-2
09/14/2020 - 14:00
U.S. FDA’s highest priority is ensuring the quality, safety, and effectiveness of vaccines
09/13/2020 - 14:18
LabCorp test detects COVID-19, Influenza A / B, or RSV which often present similar symptoms
09/10/2020 - 15:40
A single dose of the AZD1222 experimental vaccine resulted in a 4-fold increase in protective antibodies to the SARS-CoV-2 virus spike protein
09/06/2020 - 08:32
Houston Texas COVID-19 disease fatality rate reported far less than 1%
09/04/2020 - 16:32
NCPA survey finds most pharmacists intend to administer coronavirus vaccinations
09/01/2020 - 17:47
NIH Panel says data is needed to determine if using convalescent plasma for COVID-19 patients is warranted
09/01/2020 - 17:30
Cloth face coverings in educational settings may present challenges
08/28/2020 - 15:57
UNC-Chapel Hill researchers found obese people experience severe outcomes when diagnosed with COVID-19
08/28/2020 - 13:41
